Closed-loop RTMS for Short-term Migraine Prevention
RecruitingNCT06735768Phase: NAStarted 2024-12-09
Summary
Migraine is a prevalent and debilitating primary headache disorder, where patients suffer from disabling symptoms that usually consist of a moderate to severe headache lasting 4 to 72 hours, nausea an
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Univ.-Klinik für Neurologie, Medizinische Universität WienVienna, State of Vienna, Austria
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06735768